Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
N Engl J Med 2025;393:635647
Note: The Medicaid version of the BALANCE Model is still launching in May 2026, but that is entirely separate from Medicare Part D
Prior to the popularity of the GLP-1 agonist drugs, other substances were used for medication-assisted weight loss, including controlled substances
Sermorelin is a synthetic GHRH analogue not licensed in the UK for growth hormone deficiency treatment or weight management in adults
Ebrahimi-Fakhari D, Sahin M
US$ 28.28
US$ 25.57
US$ 29.07
US$ 22.35
